Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles

Stroke

Volumn 28, Issue 1, 1997, Pages 181-185

  Lang, Markus G ^a   Paternò, Roberto ^a   Faraci, Frank M ^a   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

cerebral circulation; peptides; potassium channels; rats; vasodilation

Indexed keywords

ADRENOMEDULLIN; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD VESSEL TONE; BRAIN ARTERY; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; VASCULAR ENDOTHELIUM;

EID: 0031028561     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.1.181     Document Type: Article

References (39)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993;241:271-273.
3. DeWitt BJ, Cheng DY, Caminiti GN, Nossaman BD, Coy DH, Murphy WA, Kadowitz PJ. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur J Pharmacol. 1994;257:303-306.
4. Baskaya MK, Suzuki Y, Anzai M, Seki Y, Saito K, Takayasu M, Shibuya M, Sugita K. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs. J Cereb Blood Flow Merab. 1995;15:827-834.
5. Nakamura K, Toda H, Terasako K, Kakuyama M, Hatano Y, Mori K, Kangawa K. Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn J Pharmacol. 1995;67:259-262.
6. Ichiki Y, Kitamura K, Kangawa K. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994;338:6-10.
7. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Abe K, Miura Y, Hayashi Y, Sasano H, Mouri T. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab. 1995;80:1750-1752.
8. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201:1160-1166.
9. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun. 1994;203:719-726.
10. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest. 1994;94:2158-2161.
11. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, Minami M, Yasunari K, Yoshikawa J. Plasma adrenomedullin concentrations in essential hypertension. Hypertension. 1996;27:102-107.
12. Jougasaki M, Wei CM, McKinley LJ, Burnett JCJ. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 1995;92:286-289.
13. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun. 1995; 207:25-32.
14. Shoji H, Minamino N, Kangawa K, Matsuo H. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun. 1995;215:531-537.
15. Wang X, Yue TL, Barone FC, White RF, Clark RK, Willette RN, Sulpizio AC, Aiyar NV, Ruffolo RR, Feuerstein GZ. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci U S A. 1995;92:11480-11484.
16. Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension. 1995;25:1185-1190.
17. Willette RN, Ohlstein EH, Pullen M, Sauermelch CF, Cohen A, Nambi P. Transient forebrain ischemia alters acutely endothelin receptor density and immunoreactivity in gerbil brain. Life Sci. 1993;52:35-40.
18. Wei GZ, Zhang J, Sheng SL, Ai HX, Ma JC, Lui HB. Increased plasma endothelin-1 concentration in patients with acute cerebral infarction and actions of endothelin-1 on pial arterioles of rat. Chin Med J. 1993;106:917-921.
19. Viossat I, Duverger D, Chapelat M, Pirotzky E, Chabrier PE, Braquet P. Elevated tissue endothelin content during focal cerebral ischemia in the rat. J Cardiovasc Pharmacol. 1993;22:306-309.
20. Bian LG, Zhang TX, Zhao WG, Shen JK, Yang GY. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion. Neurosci Lett. 1994;174:47-50.
21. Salom JB, Torregrosa G, Alborch E. Endothelins and the cerebral circulation. Cerebrovasc Brain Metab Rev. 1995;7:131-152.
22. + channels in CGRP-induced dilatation of basilar artery in vivo. Am J Physiol. 1993;265:H581-H585.
23. + currents in cerebral arterial smooth muscle: pharmacological and hormonal modulation. Am J Physiol. 1995;269:H1634-H1640.
24. Hong KW, Yoo SE, Yu SS, Lee JY, Rhim BY. Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles. Am J Physiol. 1996;270:H317-H323.
25. Faraci FM, Breese KR. Dilatation of cerebral arterioles in response to N-methyl-D-aspartate: role of CGRP and acetylcholine. Brain Res. 1994;640:93-97.
26. +channels. Circ Res. 1995;76:1057-1062.
27. + channels in cerebral vasodilatation induced by increases in cyclic GMP and cyclic AMP. Stroke. 1996;27:1603-1608.
28. Poyner D. Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci. 1995;16:424-428.
29. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A. Vasodilator effect of adrenomedullin and calcitonin gene related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993;196:245-251.
30. Ishizaka Y, Ishizaka Y, Tanaka M, Kitakura K, Kangawa K, Minamino N, Matsuo H, Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994;200:642-646.
31. Elhawary AM, Poon J, Pang CC. Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin. Br J Pharmacol. 1995;115:1133-1140.
32. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol. 1995; 289:383-385.
33. Kreutter DK, Orena SJ, Torchia AJ, Contillo LG, Andrews GC, Stevenson RW. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor. Am J Physiol. 1993;264:E606-E613.
34. Grace GC, Dusting GJ, Kemp BE, Martin TJ. Endothelium and the vasodilator action of rat calcitonin gene-related peptide (CGRP). Br J Pharmacol. 1987;91:729-733.
35. Crossman D, McEwan J, MacDermot J, MacIntyre I, Dollery CT. Human calcitonin gene-related peptide activates adenylate cyclase and releases prostacyclin from human umbilical vein endothelial cells. Br J Pharmacol. 1987;92:695-701.
36. Gray DW, Marshall I. Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent relaxation in rat aorta. Eur J Pharmacol. 1992;212:37-42.
37. Nishimura Y, Usui H, Suzuki A, Kajimoto N, Yamanishi Y. Relaxant response of isolated basilar arteries to calcitonin gene-related peptide in stroke-prone spontaneously hypertensive rats. Jpn J Pharmacol. 1992;59:333-338.
38. Kitazono T, Faraci FM, Taguchi H, Heistad DD. Role of potassium channels in cerebral blood vessels. Stroke. 1995;26:1713-1723.
39. Fujii K, Heistad DD, Faraci FM. Flow-mediated dilatation of the basilar artery in vivo. Circ Res. 1991;69:697-705.